HCSG · Healthcare Services Group Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $462.77M | - | $464.34M | $458.49M | $447.66M | - | $428.15M | $426.29M | $423.43M | - |
| Cost of Revenue | $386.93M | - | $367.93M | $455.53M | $379.69M | - | $364.73M | $384.74M | $358.91M | - |
| Gross Profit | $75.83M | - | $96.41M | $2.96M | $67.97M | - | $63.42M | $41.55M | $64.52M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $42.00M | - | $50.54M | $49.16M | $44.97M | - | $46.89M | $44.44M | $46.91M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $3.81M | - | $3.40M | $3.20M | $3.88M | - | $3.10M | $3.00M | $3.53M | - |
| Operating Income | $34.54M | - | $57.31M | ($41.89M) | $23.89M | - | $18.81M | ($1.99M) | $21.31M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $8.48M | - | $14.36M | ($9.52M) | $6.67M | - | $4.78M | ($198.0K) | $6.00M | - |
| Net Income | $26.06M | - | $42.95M | ($32.37M) | $17.23M | - | $14.03M | ($1.79M) | $15.31M | - |
| EPS - Basic | $0.37 | - | $0.59 | ($0.44) | $0.23 | - | $0.19 | ($0.02) | $0.21 | - |
| EPS - Diluted | $0.37 | - | $0.59 | ($0.44) | $0.23 | - | $0.19 | ($0.02) | $0.21 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136.17M | $125.19M | $124.39M | $82.82M | $64.32M | $56.78M | $27.05M | $26.43M | $29.29M | $54.33M |
| Accounts Receivable | $299.44M | $281.30M | $288.52M | $292.21M | $337.90M | $330.91M | - | - | - | $344.86M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $83.12M | $77.38M | $81.72M | $77.90M | $78.77M | $81.15M | $76.64M | $72.22M | $72.92M | $83.22M |
| Current Assets | $601.23M | $576.41M | $580.63M | $532.29M | $574.97M | $556.65M | $578.12M | $573.21M | $580.41M | $571.70M |
| Total Assets | $814.85M | $794.25M | $804.30M | $802.20M | $822.96M | $802.77M | $805.84M | $799.70M | $803.88M | $790.65M |
| Current Liabilities | $193.37M | $170.38M | $195.64M | $213.93M | $198.75M | $192.55M | $197.20M | $209.48M | $209.38M | $216.93M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $513.77M | $510.21M | $496.00M | $477.04M | $514.20M | $499.93M | $488.75M | $471.42M | $474.58M | $456.62M |
| Retained Earnings | $309.73M | $283.67M | $252.42M | $209.47M | $241.84M | $224.56M | $212.63M | $198.59M | $200.38M | $185.01M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $43.73M | - | - | - | $27.50M | - | - | - | ($26.03M) | - |
| Investing Cash Flow | ($11.55M) | - | - | - | ($14.47M) | - | - | - | $11.72M | - |
| Financing Cash Flow | ($26.68M) | - | - | - | ($8.78M) | - | - | - | $13.97M | - |
| CapEx | $1.40M | - | - | - | $1.74M | - | - | - | $2.20M | - |
| Free Cash Flow | $42.33M | - | - | - | $25.76M | - | - | - | ($28.23M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 16.4% | - | 20.8% | 0.6% | 15.2% | - | 14.8% | 9.7% | 15.2% | - |
| Operating margin | 7.5% | - | 12.3% | -9.1% | 5.3% | - | 4.4% | -0.5% | 5.0% | - |
| EBITDA margin | 8.3% | - | 13.1% | -8.4% | 6.2% | - | 5.1% | 0.2% | 5.9% | - |
| Net margin | 5.6% | - | 9.3% | -7.1% | 3.8% | - | 3.3% | -0.4% | 3.6% | - |
| Free cash flow margin | 9.1% | - | - | - | 5.8% | - | - | - | -6.7% | - |
| FCF / Net income | 1.62 | - | - | - | 1.50 | - | - | - | -1.84 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 9.1% | - | 10.9% | 10.7% | 10.0% | - | 11.0% | 10.4% | 11.1% | - |
| Effective tax rate | 24.6% | - | 25.0% | - | 27.9% | - | 25.4% | - | 28.2% | - |
| Return on assets | 3.2% | - | 5.3% | -4.0% | 2.1% | - | 1.7% | -0.2% | 1.9% | - |
| Return on equity | 5.1% | - | 8.7% | -6.8% | 3.4% | - | 2.9% | -0.4% | 3.2% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 3.11 | 3.38 | 2.97 | 2.49 | 2.89 | 2.89 | 2.93 | 2.74 | 2.77 | 2.64 |
| Quick ratio | 3.11 | 3.38 | 2.97 | 2.49 | 2.89 | 2.89 | 2.93 | 2.74 | 2.77 | 2.64 |
| Cash ratio | 0.70 | 0.73 | 0.64 | 0.39 | 0.32 | 0.29 | 0.14 | 0.13 | 0.14 | 0.25 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.59 | 1.56 | 1.62 | 1.68 | 1.60 | 1.61 | 1.65 | 1.70 | 1.69 | 1.73 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.57 | - | 0.58 | 0.57 | 0.54 | - | 0.53 | 0.53 | 0.53 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 236d | - | 227d | 233d | 276d | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 78d | - | 81d | 62d | 76d | - | 77d | 69d | 74d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 50.1x | - | 28.5x | - | 43.8x | - | 58.8x | - | 59.4x | - |
| P / B | 2.6x | - | 2.5x | 2.3x | 1.4x | - | 1.7x | 1.7x | 1.9x | - |
| P / S | 2.8x | - | 2.6x | 2.4x | 1.7x | - | 1.9x | 1.8x | 2.2x | - |
| EV / EBITDA | 30.8x | - | 18.2x | - | 24.5x | - | 36.5x | 744.5x | 36.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 3.4% | - | 8.5% | 7.6% | 5.7% | - | 4.1% | 1.8% | 1.5% | - |
| Revenue CAGR (3y) | 3.5% | - | 3.9% | 2.6% | 1.6% | - | 1.0% | 2.3% | -1.9% | - |
| Revenue CAGR (5y) | 0.6% | - | 1.3% | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 11.6% | - | 52.0% | -92.9% | 5.3% | - | 87.4% | -18.9% | 14.7% | - |
| Operating income growth (YoY) | 44.6% | - | 204.7% | -2009.2% | 12.1% | - | - | - | 21.4% | - |
| Net income growth (YoY) | 51.3% | - | 206.2% | -1710.2% | 12.5% | - | - | - | 20.7% | - |
| EPS growth (YoY) | 60.9% | - | 210.5% | -2100.0% | 9.5% | - | - | - | 23.5% | - |
| EPS CAGR (3y) | 29.6% | - | - | - | 15.3% | - | 13.5% | - | -14.0% | - |
| EPS CAGR (5y) | 2.3% | - | 9.8% | - | - | - | -5.3% | - | -4.9% | - |
| FCF growth (YoY) | 64.3% | - | - | - | - | - | - | - | -63.2% | - |
| FCF CAGR (5y) | 74.0% | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.1% | 2.1% | 1.5% | 1.2% | 8.3% | 9.5% | 10.6% | 4.6% | 7.7% | 7.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.84B totalDietary Services$1.01B · 55.1%
Environmental Services$824.70M · 44.9%
Peer comparison
Same SIC group: Services-Nursing & Personal Care Facilities
Comparing HEALTHCARE SERVICES GROUP INC against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Nov 17, 2022 | $0.2150 |
| Aug 18, 2022 | $0.2140 |
| May 19, 2022 | $0.2130 |
| Feb 24, 2022 | $0.2110 |
| Nov 18, 2021 | $0.2100 |
| Aug 19, 2021 | $0.2090 |
| May 20, 2021 | $0.2080 |
| Feb 25, 2021 | $0.2060 |
| Nov 19, 2020 | $0.2050 |
| Aug 20, 2020 | $0.2040 |
| May 21, 2020 | $0.2030 |
| Feb 27, 2020 | $0.2010 |
| Nov 21, 2019 | $0.2000 |
| Aug 22, 2019 | $0.1990 |
| May 23, 2019 | $0.1980 |
| Feb 14, 2019 | $0.1960 |
| Nov 21, 2018 | $0.1950 |
| Aug 23, 2018 | $0.1940 |
| May 24, 2018 | $0.1930 |
| Feb 15, 2018 | $0.1910 |
| Nov 16, 2017 | $0.1900 |
| Aug 16, 2017 | $0.1890 |
| May 17, 2017 | $0.1880 |
| Feb 15, 2017 | $0.1860 |